Effect of solid lipid nanoparticles (SLN) on cytokine production and the viability of murine peritoneal macrophages

Journal of Microencapsulation

Volumn 17, Issue 5, 2000, Pages 639-650

  Scholer, N ^a   Zimmermann, E ^a   Katzfey, U ^a   Hahn, H ^a   Muller, R H ^a   Liesenfeld, O ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cytokines; Cytotoxicity; Peritoneal macrophages; Solid lipid nanoparticles (SLN)

Indexed keywords

BEHENIC ACID; GLYCEROL BEHENATE; LIPID; LUTREOL TM F 68; NANOPARTICLE; PALMITIC ACID; POLOXAMER; PRECIFAC ATO; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG FORMULATION; DRUG RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOMODULATION; INFLAMMATION; MOUSE; NONHUMAN; PARTICLE SIZE; PERITONEUM MACROPHAGE; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION;

EID: 0033832155     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/026520400417685     Document Type: Article

References (34)

1. Functional diversity of helper T lymphocytes
2. Lipospheres as a vaccine carrier system: Effects of size, charge, and phospholipid composition
3. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins
4. The acute phase response
5. Relevant factors affecting the formulation and growth of lipid nanospheres suspensions
6. Peritoneal macrophages from C57BL/6 mice orally immunized with Toxoplasma gondii antigens in association with cholera toxin possess an enhanced ability to inhibit parasite multiplication
7. IL-10 inhibits cytokine production by activated macrophages
8. Stimulation of antibacterial macrophage activities by B-cell stimulatory factor 2
9. Lipospheres from microemulsions
10. Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: Activity against intracellular Leishmania donovani associated with hydrogen peroxide production
11. Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii
12. Surface characteristics and interaction of colloidal particles with mouse peritoneal macrophages
13. The influence of emulsifying agents and of lipid soluble drugs on the fractional removal rate of lipid emulsions from the blood stream of the rabbit
14. Antimicrobial functions of mononuclear phagocytes
15. Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length
16. Solid lipid nanoparticles (SLN)-Vergleichende Phagozytose- und Zytotoxizitatsuntersuchungen an humanen Granulozyten
17. Cell culture for the asessment of toxicity and uptake of polymeric particulate drug carriers
18. Comparison of cytotoxicity between polyester nanoparticles and solid lipid nanoparticles (SLN)
19. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
20. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
21. Solid lipid nanoparticles (SLN) as potential carrier for human use: Interaction with human granulocytes
22. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
23. Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery
24. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant
25. Interaction of differentiated HL60 cells with poloxamer and poloxamine surface modified model drug carriers
26. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. II. Effect of surface modification by coating of particles with poloxamer on the phagocytic uptake
27. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and its correlation to particle properties and in vivo distribution
28. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterisation and sterilisation
29. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12
30. Submicron-sized parenteral carrier systems based on solid lipids
31. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes
32. The mononuclear phagocyte system. A new classification of macrophages and their precursor cells
33. Gram-negative sepsis